TP53 and cancer: To experimentally verify the proliferation/growth-suppressive roles of the PSLRs in cancer cells and evaluate consequences independent of any drug effects that induce p53, we engineered A549 LUAD cells to express PSLR-1, PSLR-2, or vehicle control.